|
|
||||||||
Department of Physiological Sciences, Eastern Virginia Medical School, Norfolk, Virginia 23501
| |
ABSTRACT |
|---|
|
|
|---|
Stimulation of receptors causing arterial contraction may also cause attenuation of cell responsiveness to stimuli. This study tested the hypothesis that attenuation of receptor-induced contractions involves Ca2+ desensitization. Renal artery rings were pretreated with 10 µM phenylephrine (PE), relaxed with PE washout (plus phentolamine), and then activated by histamine (HA). Pretreatment for 30 min resulted in a rightward shift in the concentration-contraction curve to HA by ~1/2 log without a reduction in the slope or maximum response. For example, control and PE-pretreated tissues responded to 0.56 µM HA with strong (0.95 F/Fo) and weak (0.16 F/Fo) contractions, respectively, where F/Fo represents contractile force. This reduced reactivity was completely reversed within 90 min. In fura-loaded tissues, PE pretreatment caused less of a rightward shift in the HA concentration-intracellular free Ca2+ concentration ([Ca2+]i) curve than in the HA concentration-contraction curve. A dissociation between force and [Ca2+]i was also produced when KCl was used instead of HA. These data suggest that the reduced reactivity produced by PE pretreatment involved, in part, a reduction in the ability of HA to increase the Ca2+ sensitivity of contractions. These data support the hypothesis that the degree of stimulus-induced Ca2+ sensitization of contractions is dependent on the history of receptor activation.
heterologous desensitization; fura 2; rabbit renal artery; isometric force; phenylephrine; histamine; vascular smooth muscle
| |
INTRODUCTION |
|---|
|
|
|---|
AN EPISODE OF EXPOSURE to a G protein-linked receptor stimulus not only causes an immediate response but also may induce desensitization, causing the tissue to subsequently display decreased reactivity to receptor stimuli (26). The classic explanation for this attenuation of cell responsiveness to a ligand is receptor desensitization (19, 26). However, several lines of evidence suggest that reductions in postreceptor signaling systems may also play a role (3, 9, 16, 22, 30).
Homologous and heterologous desensitization are the terms currently
used to describe the overall phenomenon of postactivation attenuation
of cell responsiveness (19, 26). Homologous receptor desensitization
involves a reduction in same-receptor responsiveness. The mechanisms
behind this effect have been rigorously studied by Lefkowitz and others
(19), who show, for example, that
-adrenergic receptor stimulation
can activate receptor kinases, leading to
-adrenergic receptor
desensitization and ultimately to a reduction in
-adrenergic
receptor numbers. Heterologous desensitization is, by definition, a
more complex modulatory mechanism consisting of desensitization of
receptors other than that stimulated to cause the desensitization or
desensitization resulting from modulation of postreceptor signaling
systems (26).
Desensitization of vascular smooth muscle contractions is a well-known
phenomenon, but the precise subcellular mechanisms responsible for this
adaptive response remain to be determined. Homologous
-adrenergic
receptor desensitization occurs in cultured vascular smooth muscle
cells, but to induce this response, cells appear to require stimulation
periods in excess of several hours (3, 11). Interestingly, stimulation
of intact rat arterial muscle with epinephrine for 12 h does not reduce
-adrenergic receptor numbers or affinity, but
-receptor-induced
contractile activity is greatly diminished, implying that postreceptor
desensitization is activated by the prolonged receptor stimulation
period (16).
Recent evidence shows that shorter episodes of receptor activation (<1 h) of rabbit femoral artery (22), hog carotid artery (30), or rabbit detrusor (28) reduce KCl-induced contractile activity. Because KCl produces contractions by causing membrane depolarization rather than acting as a receptor stimulus, these results indicate that short periods of receptor stimulation can desensitize signaling systems downstream from receptor activation in smooth muscle.
If receptor stimulation can reduce reactivity of smooth muscle to KCl by activating a postreceptor desensitizing mechanism, then stimulation of a receptor type other than that used to produce desensitization may also be affected by this mechanism. One modulatory mechanism that plays a key role in regulation of smooth muscle contractile reactivity involves changes in the Ca2+ sensitivity of contractions (29). In particular, receptor agonists increase Ca2+ sensitivity, whereas agents that increase cGMP decrease Ca2+ sensitivity (12, 13). In short, by changing Ca2+ sensitivity, the level of contraction may be greatly increased or decreased without considerable changes in the concentration of cytosolic free Ca2+ ([Ca2+]i). The goal of the present study was to test the hypothesis that heterologous postreceptor desensitization involves, at least in part, a reduction in Ca2+ sensitivity of receptor-induced contractions.
| |
METHODS |
|---|
|
|
|---|
Tissue preparation.
Tissues were prepared as described previously (22). Renal arteries
obtained from female New Zealand White rabbits were cleaned of adhering
tissue and stored for
48 h in cold (0-4°C) physiological saline solution (PSS) composed of (in mM) 140 NaCl, 4.7 KCl, 1.2 MgSO4, 1.6 CaCl2, 1.2 Na2HPO4,
2.0 MOPS (adjusted to pH 7.4 at either 0 or 37°C, as appropriate),
0.02 Na2-EDTA (to chelate trace heavy metals), and 5.6 D-glucose. High-purity (>17
M
distilled and deionized) water was used throughout. Before
arterial muscle rings were secured between a micrometer and an
isometric force transducer (model 52, Harvard Apparatus, South Natick,
MA) in water-jacketed muscle chambers (Radnoti Glass Technology,
Monrovia, CA), the endothelium was removed by gently rubbing the
intimal surface with a metal rod, and the adventitia was removed by microdissection.
Isometric force.
Contractile force (F) was measured
as described previously (22). Tissues were allowed to equilibrate at
37°C for 1 h, and the muscle length at which active force was
maximum (Lo)
was then determined for each tissue with
K+ as agonist (110 mM KCl
substituted isosmotically for NaCl) using an abbreviated length-tension
curve (8, 22). Once tissues were stretched to
Lo, no further
length changes were imposed. For each tissue, the degree of
steady-state F produced at
Lo by incubation
for 5-10 min in 110 mM KCl was equal to the optimal force for
muscle contraction
(Fo), and
subsequent contractions were calculated as
F/Fo.
Tissues contracted with phenylephrine (PE) were relaxed by PE washout
in the presence of 1 µM phentolamine (
-adrenergic receptor
antagonist). In tissues contracted with histamine (HA), 1 µM
cimetidine (H2-receptor blocker)
was added 10 min before the addition of HA. In tissues contracted with
KCl, 1 µM phentolamine was added to block potential
-adrenergic
receptor activation caused by the release of norepinephrine from
periarterial nerves. To perform concentration-response curves, HA or
KCl was added cumulatively every 7-10 min.
Intracellular free
Ca2+
concentration.
[Ca2+]i
was measured as described previously (24). Arterial rings secured
between a micrometer and an isometric force transducer and positioned
in front of a quartz window in a custom-fabricated water-jacketed
muscle chamber (Radnoti Glass Technology) were loaded for 2.5 h with 10 µM fura 2-AM (Molecular Probes, Eugene, OR) plus Pluronic F-127
(0.01% wt/vol) to enhance solubility. Tissues were washed for 30 min
and, in response to alternate excitation at 340 and 380 nm with the use
of a rotating filter wheel, fluorescence emissions at 500 nm for each
excitation wavelength (F340 and
F380) were collected by a
photomultiplier tube and amplified (model 1642, Ithaco), digitized
(Data Translations DT2811), and visualized on a computer screen (CODAS
software package, DATAQ Instruments). [Ca2+]i
(in nM) was calculated using the formula
[Ca2+]i = [(R
Rmin)/(Rmax
R)] × (Sf/Sb) × Kd, where
Rmin and
Rmax are the ratios produced,
respectively, in a Ca2+-free
solution (PSS containing 0 mM
CaCl2, 5 mM EGTA, 110 mM KCl substituted for NaCl, and 20 µM ionomycin) and in the presence of
excess Ca2+ (PSS containing 3.6 mM
CaCl2, 110 mM KCl substituted for
NaCl, and 20 µM ionomycin);
Sf/Sb
is the ratio of F380 in the
Ca2+-free solution to
F380 in the presence of excess
Ca2+; and
Kd is the
dissociation constant (224 nM) (7). All fluorescence measurements were
corrected for tissue background fluorescence by adding 4 mM
MnCl2 to the
Rmax solution to quench the fura 2 signal at the end of the experiment. Fluorescence ratios
(F340/F380) taken in resting (0.36 ± 0.01) and fully contracted (0.36 ± 0.01, n = 21, P > 0.05) tissues before being
loaded with fura 2-AM were not different, indicating that contractions,
per se, had no effect on ratiometric tissue fluorescence. Furthermore,
a comparison of F340 and
F380 fluorescence values taken
after the 4 mM MnCl2 quench at the
end of the experiment (0.35 ± 0.03 and 1.06 ± 0.11, respectively) with those values taken before the fura 2-AM loading (0.33 ± 0.03 and 0.97 ± 0.11, respectively,
n = 21, P > 0.05) were not different,
suggesting that signal interference from fluorescent intermediates
potentially produced by partial hydrolysis of fura 2-AM was negligible.
Statistics. For analyses of concentration-response data for each tissue, a curve-fitting program (GraphPad) was used to obtain the four parameters of a sigmoidal curve [maximum, minimum, slope, and concentration producting half-maximum contraction (EC50)]. For statistical analyses of logarithmic data (i.e., EC50 values), geometric means were used (5). For convenience, log EC50 values were converted to EC50 values in micromoles per liter in the text. To construct Fig. 5, Ca2+ values for each tissue were converted so that values ranged between 0 and 1. This was accomplished by dividing the difference between the agonist-stimulated value and the curve-fitted minimum value (in nM) by the difference between the curve-fitted maximum and minimum values (in nM), represented as Ca/Camax.
The null hypothesis was examined using one-way ANOVA. To determine differences between groups, the Student-Newman-Keuls post hoc test was used. When two groups were compared, the Student's t-test was used. In all cases, the null hypothesis was rejected at P < 0.05. For each study described, the value of n was equal to the number of rabbits from which arteries were obtained.| |
RESULTS |
|---|
|
|
|---|
Effect of PE pretreatment on HA-induced contractions.
An HA-induced concentration-contraction curve produced in rabbit renal
artery not loaded with the Ca2+
indicator fura 2 (Fig. 1) was characterized
by an EC50 of 0.30 ± 0.06 µM, a slope of 4.75 ± 0.70, and a maximum response of 1.01 ± 0.01 F/Fo
(n = 3). In tissues pretreated for 30 min with 10 µM PE and washed for 10 min before addition of the first
HA concentration, the HA-induced concentration-contraction curve
was characterized by an ~1/2 log rightward shift in the
EC50 to 0.93 ± 0.08 µM
(P < 0.05 compared with control)
without a change in the slope (3.94 ± 0.69) or maximum response
(0.96 ± 0.04 F/Fo,
n = 3; Fig. 1).
|
|
|
Effect of PE pretreatment on HA-induced increases in
[Ca2+]i.
In tissues loaded with the Ca2+
indicator fura 2, HA produced a concentration-contraction curve that
was similar to that produced by tissues not loaded with fura 2 (compare
Figs. 4A
and 1). In fura 2-loaded tissues, PE pretreatment (30 min at 10 µM
followed by 10-min PE washout and relaxation) caused a rightward shift in the HA concentration-contraction curve as it did in tissues not
loaded with fura 2 (EC50: control = 0.32 ± 0.03 µM, PE pretreated = 0.75 ± 0.05 µM,
n = 4, P < 0.05; Fig.
4A). Likewise, as in tissues not
fura 2 loaded, both the slope of the curve and the maximum response
were not different from the control values (slope: control = 5.41 ± 0.56, PE pretreated = 4.47 ± 0.74; maximum response: control = 1.04 ± 0.02 F/Fo,
PE pretreated = 1.01 ± 0.05 F/Fo). This PE pretreatment also produced a rightward shift in the HA concentration-[Ca2+]i
curve (EC50: control = 0.31 ± 0.03 µM, PE pretreated = 0.54 ± 0.07 µM,
n = 4, P < 0.05; Fig.
4B). However, the slope of the curve
produced by tissues that had been PE pretreated was approximately twofold greater than that of the control response (slope: control = 3.71 ± 0.55, PE pretreated = 6.27 ± 0.81, n = 4, P < 0.05; Fig. 4B). The minimum and maximum
[Ca2+]i
responses produced by control tissues and tissues that had been
pretreated with PE were identical (minimum: control = 61 ± 10 nM,
PE pretreated = 62 ± 6 nM; maximum: control = 278 ± 30, PE pretreated = 266 ± 33 nM; Fig.
4B).
|
|
Relationship between HA-induced increases in contraction and
[Ca2+]i.
To examine the dependency of steady-state force on
[Ca2+]i
in tissues activated by HA, data from Fig. 5 were plotted as shown in
Fig. 6A.
The relationship between force and
Ca/Camax for control tissues was
linear, with a slope just slightly greater than unity (1.18, Fig.
6A); that is, nearly a one-to-one
relationship existed between HA-induced increases in
Ca2+ and force. However, in
tissues that were pretreated for 30 min with 10 µM PE, the
relationship between increases in
Ca2+ and force was different from
that produced in control tissues. When
Ca2+ data were considered that
showed an increase from the lowest point to the earliest point
achieving near-maximum
[Ca2+]i
(i.e., ~250 nM
[Ca2+]i
produced by 0.78 µM HA; see Fig.
4B), the slope of the relationship between Ca/Camax and force was
significantly less than that of the control (0.62, P < 0.05), and the maximum increase
in Ca/Camax produced at 0.78 µM
HA corresponded with an increase in force of 0.6 ± 0.07 F/Fo
(Fig. 6A, shaded square).
This force value was significantly less than the control force value
(1.03 ± 0.04) that produced an identical increase in
Ca/Camax of 0.92-fold
Camax (Fig.
6A, shaded circle). Thus PE-pretreated
tissues displayed a reduced sensitivity of contractions to increases in
[Ca2+]i.
Further increases in HA concentration above 0.78 µM produced additional increases in force without an additional increase in [Ca2+]i
(see Fig. 4B), suggesting that
tissues regained normal sensitivity at higher HA concentrations or with
a combination of higher HA concentrations and time. These data were
similar to those produced when tissues were stimulated with increasing
KCl concentrations rather than increasing HA concentrations (Fig.
6B); that is, after pretreatment of
tissues for 30 min with 10 µM PE followed by a 10-min relaxation
period, 25 mM KCl (Fig. 6B, shaded
square) produced an increase in
Ca/Camax statistically identical
to that produced by control tissues stimulated with 40 mM KCl (Fig.
6B, shaded circle), but produced a
much weaker increase in force (0.20 ± 0.08 vs. 0.73 ± 0.06 F/Fo,
P < 0.05) (Fig.
6B). The relationship between
Ca2+ and force for KCl-stimulated
tissues fit an exponential better than a linear curve; that is,
r2 values for
exponential and linear curve fits were, respectively, 0.92 and 0.83 for
control data and 0.85 and 0.53 for PE-pretreatment data. The reason for
the apparent difference in the form of the relationship between force
and Ca2+ when HA and KCl were
compared was not pursued further. The
Ca2+-force curve produced by
tissues stimulated with KCl and pretreated with PE was significantly
different from the KCl-stimulated control curve
(P < 0.05). Interestingly, when
these four plots were compared together, for a given moderate increase
in Ca2+ (e.g., 0.7-fold
Camax; Fig. 7, dotted lines),
tissues from the HA control group produced the highest force
(~0.7-fold
Fo), KCl after
PE-pretreatment produced the lowest force (~0.2-fold
Fo), and HA
after PE pretreatment or KCl control fell in between these extremes
(~0.4-fold
Fo) (Fig.
7).
|
|
| |
DISCUSSION |
|---|
|
|
|---|
The degree of reactivity of renal artery to HA was found to be
dependent on the recent history of receptor activation. For example,
stimulation of rabbit renal artery
1-adrenergic receptors with 10 µM PE for a short duration (30 min) reduced the ability of this
tissue to subsequently respond to stimulation by another receptor type,
H1-histaminergic receptors, for
90 min after cessation of the initial PE stimulation. Reduced
reactivity to HA may have been caused by reductions in
H1-receptor numbers, receptor-G
protein coupling, or other components of stimulus-contraction coupling beyond receptor activation, such as
Ca2+ mobilization or regulation of
Ca2+ sensitivity of contractions.
This is the first study to provide evidence in support of the
hypothesis that the degree of receptor-stimulated Ca2+ sensitization of contractions
can be reversibly attenuated by a prior short episode of receptor activation.
One important regulatory mechanism that operates downstream from receptor activation involves changes in the degree of Ca2+ sensitivity of contractions (12, 17, 29). Receptor stimulation immediately increases the Ca2+ sensitivity of contractions by activation of the low-molecular-weight G protein RhoA (6), resulting in a force-to-[Ca2+]i ratio greater than that produced by K+-depolarization (12, 29); that is, the level of force produced for a given level of [Ca2+]i is greater during receptor activation than during K+-depolarization (12). Moreover, the two major physiological mechanisms causing smooth muscle relaxation, namely, increases in cGMP and cAMP, cause reductions in Ca2+ sensitivity (12, 13, 14). However, contractile receptor ligands and agents that elevate cellular levels of cyclic nucleotides also alter [Ca2+]i (12, 23). Thus smooth muscle utilizes at least two mechanisms to regulate the level of contraction, namely, changes in [Ca2+]i and changes in Ca2+ sensitivity.
In the present study, prior exposure of rabbit renal artery to 10 µM
PE for only 30 min caused a greater reduction in the sensitivity of
HA-induced contractions than of HA-induced increases in
[Ca2+]i;
that is, PE pretreatment reduced the ability of HA to increase force
more than it reduced the ability of HA to increase
[Ca2+]i.
Thus the most novel aspect of the work presented here is the evidence
suggesting that
1-adrenergic
receptors can induce a mechanism that temporarily reduces the ability
of receptor stimuli to subsequently produce increases in
Ca2+ sensitivity of contractions.
The significance of this finding is that it adds a new dimension to
receptor-induced alterations in
Ca2+ sensitivity. These data
support the hypothesis that the degree of increase in
Ca2+ sensitivity is a variable
dependent on the activation history of the vascular smooth muscle cell.
In this scenario, naive cells would produce greater increases in
Ca2+ sensitivity than cells that
had recently been stimulated with a maximum concentration of
contractile receptor agonist.
Attenuation of cell responsiveness to extracellular ligands is a
well-known cellular regulatory mechanism that may function to maintain
target cell function within normal, physiological limits (19, 26).
Currently, the primary explanation for receptor-induced attenuation of
cell responsiveness is receptor-response uncoupling and subsequent
reductions in receptor numbers (19). However, studies of smooth muscle
show that a reduction in the numbers or affinity of
-adrenergic
receptors to agonists is not sufficient to explain reductions in
agonist reactivity (3, 16). An alternative explanation is that some
agonists not only stimulate contractions but also may induce
desensitization of signaling systems downstream from the receptor.
Perhaps the strongest argument that postreceptor mechanisms play a role
in short-term receptor-induced attenuation of responsiveness is that
the strength of KCl-induced contractions can be reduced in arteries
with a history of receptor activation (22, 30). KCl bypasses receptors,
producing contractions by causing membrane depolarization. Thus the
subsequent reduction in tissue reactivity to KCl caused by pretreatment
with a receptor ligand could not be the result of receptor
downregulation but must be due to some postreceptor desensitization of
cell signaling.
If receptor activation is required to activate RhoA to increase
Ca2+ sensitivity, then in cells
activated by KCl, RhoA should not be activated, and
Ca2+ sensitivity should be low.
However, a recent study (25) and data from the present study show that
PE pretreatment reduces the Ca2+
sensitivity of KCl-induced contractions, suggesting that RhoA is
activated by KCl, as well as by receptor ligands, or that RhoA is
basally active. A recent study suggests that the former case is more
likely because incubation of portal vein with DC3B, a cell-permeable
inhibitor of RhoA, significantly inhibited KCl-induced contractions but
had no effect on the pCa-tension curve in
-toxin-permeabilized tissues (6). Moreover, Yanagisawa and Okada (31) have shown that
K+ depolarization increases
Ca2+ sensitivity of arterial
contractions. These data taken together support the hypothesis that
RhoA is not active in resting vascular smooth muscle but that both
receptor activation and membrane depolarization induce RhoA activation
leading to increases in Ca2+
sensitivity and that the ability of either a receptor ligand or KCl to
activate RhoA may be reduced by prior strong receptor activation.
Moreover, data from the present study support the hypothesis that only
in naive arteries do receptor agonists increase Ca2+ sensitivity above that
produced by KCl, whereas in arteries with a recent history of strong
receptor activation, agonist-induced Ca2+ sensitization may not
necessarily exceed that produced by KCl. For example, in arteries
pretreated with 10 µM PE for 30 min and then relaxed for 10 min
(i.e., in arteries with a history of
1-adrenergic receptor
activation), HA-induced Ca2+
sensitization was roughly equivalent to that induced by KCl (see Fig.
7).
Activation of the modulatory mechanism resulting in reduced reactivity
to HA was dependent on both the concentration of PE and duration of
1-receptor stimulation.
Moreover, the modulatory mechanism was completely reversible,
suggesting that it was a physiologically relevant mechanism and not due
to rundown of the tissue. Reduced reactivity to HA was evident when
tissues were pretreated with PE for as a short a duration as 10 min,
but the concentration of PE required to reduce subsequent HA reactivity was greater than that required to produce half-maximum contractions. Thus, compared with
-adrenergic receptor downregulation in vascular smooth muscle, which appears to take many hours to occur (3, 11, 16),
this modulatory mechanism was "switched on" very rapidly.
Moreover, although desensitization did not occur at low levels of
receptor activation, very high concentrations were also not required.
PE is less potent than norepinephrine at causing contractions in rabbit
renal arteries. For example, 10 µM PE and 0.32 µM norepinephrine
produce nearly equivalent activation of arteries (18). Because intra-
and perisynaptic norepinephrine concentrations in the rabbit ear artery
range from 0.5 to 0.7 µM, and those in guinea pig uterine artery and
rat portal vein are ~10 µM (1), muscle activation by 10 µM PE may
be regarded as reflecting levels of
1-adrenergic stimulation within
the moderate-to-high physiological range.
Vascular smooth muscle cells contain many more receptors than are
required to produce maximum responses (i.e., the receptors are spare in
number; Ref. 27). For example, to produce half-maximum contractions in
rabbit ear artery requires activation of as little as 1% of the total
-adrenergic receptor pool (20), and maximum contractions are
achieved in rabbit renal arteries when only 23% of the total
-adrenergic receptors are occupied (21). The precise role that spare
receptors play in normal physiology is a matter of speculation.
However, it is clear that spare receptors are not functionally distinct
receptors but are simply "extra" receptors that, when stimulated,
do not contribute further to the particular response measured because
the response is already maximal (2). Results from the present study
support the notion that, in rabbit arterial smooth muscle, one function
of spare receptors is to "notify" the cell that enough receptor
ligand exists in the extracellular milieu to produce maximum
contractions. This "notification" involves, in part, activation
of a signaling system targeting
Ca2+ sensitivity of the
contractile apparatus such that the ability of receptor stimuli to
increase Ca2+ sensitivity is
temporarily attenuated.
PE pretreatment caused a rightward shift in both HA-contraction and
HA-[Ca2+]i
curves. The finding that the HA-contraction curve was shifter farther
to the right than the
HA-[Ca2+]i
curve indicated that PE-pretreatment induced a decrease in Ca2+ sensitivity. However, the
fact that the
HA-[Ca2+]i
curve was shifted to the right compared with that for control tissues
suggests that PE pretreatment also induced a dissociation between
receptor activation and mobilization of
[Ca2+]i.
Additional studies are required to determine whether this effect
involved alterations in the type or efficacy of linkage between
activated receptors and G proteins or in regulation of Ca2+ influx, release, uptake, or
efflux. Indeed, there are several exciting possibilities to be examined
on the basis of recent literature. With the advent of the three-state
model of receptor activation (15), changes in agonist potency may be
explained by changes in active conformation and G protein coupling, and
it may be proposed that PE pretreatment reduced the effectiveness of
receptor-G protein coupling. Regulators of G protein signaling (RGS)
proteins accelerate GTP hydrolysis of G
subunits and have been
implicated as effector antagonists (10). Thus enhanced RGS activity
produced by PE pretreatment could theoretically have reduced the
potency of HA-induced increases in
[Ca2+]i.
Lastly, Ca2+ channels and pumps
are known to be regulated, and PE-induced downregulation of
Ca2+ influx through L-type
Ca2+ channels has been shown to
occur in vascular smooth muscle (4).
In summary, the present study indicates that
1-adrenergic receptor
activation in rabbit renal artery not only caused strong contractions
but also initiated a mechanism causing subsequent attenuation of
reactivity to HA, as reflected by a large (~1/2 log) rightward
shift in the HA-contraction curve and a moderate (~1/4 log)
rightward shift in the
HA-[Ca2+]i
curve. These dramatic effects were produced after only a 30-min stimulation with 10 µM PE, but the reduced reactivity completely reversed within 90 min. Because the rightward shift in the
HA-[Ca2+]i
curve was significantly less than the rightward shift in the HA-contraction curve, these data suggest that the reduced reactivity involved, in part, a reduction in the ability of HA to increase the
Ca2+ sensitivity of contractions.
These data support the hypothesis that the degree of stimulus-induced
Ca2+ sensitization of contractions
is dependent on the history of receptor activation.
| |
ACKNOWLEDGEMENTS |
|---|
The technical assistance of Paul-Michael Salomonsky is gratefully acknowledged. Also, my gratitude extends to Dr. Frank A. Lattanzio for access to his fluorometer.
| |
FOOTNOTES |
|---|
This work was supported by a grant from the American Heart Association, Virginia Affiliate.
The costs of publication of this article were defrayed in part by the payment of page charges. The article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. §1734 solely to indicate this fact.
Address for reprint requests and other correspondence: P. H. Ratz, Dept. of Physiological Sciences, Eastern Virginia Medical School, PO Box 1980, Norfolk, VA 23501 (E-mail: ratz{at}borg.evms.edu).
Received 31 December 1998; accepted in final form 24 May 1999.
| |
REFERENCES |
|---|
|
|
|---|
1.
Bevan, J. A.,
and
C. Su.
Variation of intra- and perisynaptic adrenergic transmitter concentrations with the width of synaptic cleft in vascular tissue.
J. Pharmacol. Exp. Ther.
190:
30-38,
1974
2.
Bourne, H. R.
Basic and Clinical Pharmacology (7th ed.). Norwalk, CT: Appleton and Lange, 1998, p. 9-33.
3.
Colucci, W. S.,
and
R. W. Alexander.
Norepinephrine-induced alteration in the coupling of
1-adrenergic receptor occupancy to calcium efflux in rabbit aortic smooth muscle cells.
Proc. Natl. Acad. Sci. USA
83:
1743-1746,
1986
4.
Declerck, I.,
B. Himpens,
G. Droogmans,
and
R. Casteels.
The
1-agonist phenylephrine inhibits voltage-gated Ca2+ channels in vascular smooth muscle cells of rabbit ear artery.
Pflügers Arch.
417:
117-119,
1990[Medline].
5.
Fleming, W. W.,
D. P. Westfall,
I. S. De La Lande,
and
L. B. Jellet.
Log-normal distribution of equieffective doses of norepinephrine and acetylcholine in several tissues.
J. Pharmacol. Exp. Ther.
181:
339-345,
1972
6.
Fujihara, H.,
L. A. Walker,
M. C. Gong,
E. Lemichez,
P. Boquet,
A. V. Somlyo,
and
A. P. Somlyo.
Inhibition of RhoA translocation and calcium sensitization by in vivo ADP-ribosylation with the chimeric toxin DC3B.
Mol. Biol. Cell
8:
2437-2447,
1997
7.
Grynkiewicz, G.,
M. Poenie,
and
R. Y. Tsien.
A new generation of Ca2+ indicators with greatly improved fluorescence properties.
J. Biol. Chem.
260:
3440-3450,
1985
8.
Herlihy, J. T.,
and
R. A. Murphy.
Length-tension relationship of smooth muscle of the hog carotid artery.
Circ. Res.
33:
257-283,
1973.
9.
Hishinuma, S.,
Y. Matsumoto,
M. K. Uchida,
and
M. Kurokawa.
Novel regulation of muscarinic receptors and their coupling with G proteins in smooth muscle: transient resensitization during desensitizing process.
Br. J. Pharmacol.
109:
330-335,
1993[Medline].
10.
Huang, C.,
J. R. Hepler,
A. G. Gilman,
and
S. M. Mumby.
Attenuation of Gi- and Gq-mediated signaling by expression of RGS4 and GAIP in mammalian cells.
Proc. Natl. Acad. Sci. USA
94:
6159-6163,
1997
11.
Izzo, N. J., Jr.,
C. E. Seidman,
S. Collins,
and
W. S. Colucci.
1-Adrenergic receptor mRNA level is regulated by norepinephrine in rabbit aortic smooth muscle cells.
Proc. Natl. Acad. Sci. USA
97:
6268-6271,
1990.
12.
Karaki, H.
Ca2+ localization and sensitivity in vascular smooth muscle.
Trends Pharmacol. Sci.
10:
320-325,
1989[Medline].
13.
Kawada, T.,
A. Toyosato,
M. O. Islam,
Y. Yoshida,
and
S. Imai.
cGMP-kinase mediates cGMP- and cAMP-induced Ca2+ desensitization of skinned rat artery.
Eur. J. Pharmacol.
323:
75-82,
1997[Medline].
14.
Lee, M. R.,
L. Lin,
and
T. Kitazawa.
Cyclic GMP causes Ca2+ desensitization in vascular smooth muscle by activating the myosin light chain phosphatase.
J. Biol. Chem.
272:
5063-5068,
1997
15.
Leff, P.,
C. Scaramellini,
C. Law,
and
K. McKechnie.
A three-state receptor model of agonist action.
Trends Pharmacol. Sci.
18:
355-362,
1997[Medline].
16.
Lurie, K. G.,
G. Tsujimoto,
and
B. B. Hoffman.
Desensitization of alpha-1 adrenergic receptor-mediated vascular smooth muscle contraction.
J. Pharmacol. Exp. Ther.
234:
147-152,
1985
17.
Nishimura, J.,
M. Kolber,
and
C. van Breemen.
Norepinephrine and GTP-
-S increase myofilament Ca2+ sensitivity in
-toxin permeabilized arterial muscle.
Biochem. Biophys. Res. Commun.
157:
677-683,
1988[Medline].
18.
Owen, M. P.
Functional characterization of alpha adrenoceptors on rabbit intrarenal arteries in vitro.
J. Pharmacol. Exp. Ther.
265:
807-812,
1993
19.
Perkins, J. P.,
W. P. Hausdorff,
and
R. J. Lefkowitz.
Mechanisms of ligand-induced desensitization of beta-adrenergic receptors.
In: The Beta-Adrenergic Receptors, edited by J. P. Perkins. Totowa, NJ: Humana, 1991, p. 73-124.
20.
Purdy, R. E.,
D. W. Ashbrook,
G. L. Stupecky,
and
M. Y. Watanabe.
Qualitative and quantitative differences between the postsynaptic alpha adrenoceptors of rabbit ear artery and thoracic aorta.
J. Pharmacol. Exp. Ther.
224:
543-551,
1983
21.
Ratz, P. H.
High
1-adrenoceptor occupancy decreases relaxing potency of nifedipine by increasing myosin light chain phosphorylation.
Circ. Res.
72:
1308-1316,
1993
22.
Ratz, P. H.
Receptor activation induces short-term modulation of arterial contractions: Memory in vascular smooth muscle.
Am. J. Physiol.
269 (Cell Physiol. 38):
C417-C423,
1995
23.
Ratz, P. H.,
M. M. Gleason,
and
S. F. Flaim.
Simultaneous measurement of force and calcium uptake during acetylcholine-induced endothelium-dependent relaxation of rabbit thoracic aorta.
Circ. Res.
60:
31-38,
1987
24.
Ratz, P. H.,
and
F. A. Lattanzio.
L-type Ca2+ channel desensitization by F
reduces PhE-induced increase in [Ca2+]i but not stress.
Am. J. Physiol.
262 (Cell Physiol. 31):
C621-C627,
1992
25.
Ratz, P. H.,
F. A. Lattanzio, Jr.,
and
P.-M. Salomonsky.
Memory of arterial receptor activation involves reduced [Ca2+]i and desensitization of cross bridges to [Ca2+]i.
Am. J. Physiol.
269 (Cell Physiol. 38):
C1402-C1407,
1995
26.
Ross, E. M.
Goodman and Gilman's Pharmacological Basis of Therapeutics (9th ed.). New York: McGraw-Hill, 1996, p. 29-41.
27.
Ruffolo, R. R., Jr.,
A. J. Nichols,
J. M. Stadel,
and
J. P. Hieble.
Structure and function of
-adrenoceptors.
Pharmacol. Rev.
43:
475-505,
1991[Medline].
28.
Shenfeld, O. Z.,
C. W. Morgan,
and
P. H. Ratz.
Bethanechol activates a post-receptor negative feedback mechanism in rabbit urinary bladder smooth muscle.
J. Urol.
159:
252-257,
1998[Medline].
29.
Somlyo, A. P.,
and
A. V. Somlyo.
Signal transduction and regulation in smooth muscle.
Nature
372:
231-236,
1994[Medline]
30.
Wardle, R. L.,
J. D. Strauss,
C. M. Rembold,
and
R. A. Murphy.
Heterologous desensitization of smooth muscle to K+ depolarization: retarded stimulus-[Ca2+]i coupling.
Am. J. Physiol.
272 (Cell Physiol. 41):
C1810-C1820,
1997
31.
Yanagisawa, T.,
and
Y. Okada.
KCl depolarization increases Ca2+ sensitivity of contractile elements in coronary arterial smooth muscle.
Am. J. Physiol.
267 (Heart Circ. Physiol. 36):
H614-H621,
1994
This article has been cited by other articles:
![]() |
M. Porter, M. C. Evans, A. S. Miner, K. M. Berg, K. R. Ward, and P. H. Ratz Convergence of Ca2+-desensitizing mechanisms activated by forskolin and phenylephrine pretreatment, but not 8-bromo-cGMP Am J Physiol Cell Physiol, June 1, 2006; 290(6): C1552 - C1559. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. H. Ratz, K. M. Berg, N. H. Urban, and A. S. Miner Regulation of smooth muscle calcium sensitivity: KCl as a calcium-sensitizing stimulus Am J Physiol Cell Physiol, April 1, 2005; 288(4): C769 - C783. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. H. Urban, K. M. Berg, and P. H. Ratz K+ depolarization induces RhoA kinase translocation to caveolae and Ca2+ sensitization of arterial muscle Am J Physiol Cell Physiol, December 1, 2003; 285(6): C1377 - C1385. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. Pfitzer Signal Transduction in Smooth Muscle: Invited Review: Regulation of myosin phosphorylation in smooth muscle J Appl Physiol, July 1, 2001; 91(1): 497 - 503. [Abstract] [Full Text] [PDF] |
||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Visit Other APS Journals Online |